These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 9489820
41. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Bérubé R, Bélanger P, Berger L, Gilbert L, Martel C, Balser J. Menopause; 2009; 16(5):897-906. PubMed ID: 19436226 [Abstract] [Full Text] [Related]
52. The association of dehydroepiandrosterone sulphate levels with bone mineral density in systemic lupus erythematosus. Formiga F, Moga I, Nolla JM, Navarro MA, Bonnin R, Roig-Escofet D. Clin Exp Rheumatol; 1997 Feb; 15(4):387-92. PubMed ID: 9272299 [Abstract] [Full Text] [Related]
55. [Hormonal modulation in disseminated lupus erythematosus: the preliminary results with danazol and cyproterone acetate]. Jungers P, Liote F, Pelissier C, Viriot J, Laurent MC, Athea N, Dougados M, Lesavre P, Kuttenn F, Bach JF. Ann Med Interne (Paris); 1986 Feb; 137(4):313-9. PubMed ID: 2946256 [Abstract] [Full Text] [Related]
56. Dehydroepiandrosterone for systemic lupus erythematosus. Crosbie D, Black C, McIntyre L, Royle PL, Thomas S. Cochrane Database Syst Rev; 2007 Oct 17; 2007(4):CD005114. PubMed ID: 17943841 [Abstract] [Full Text] [Related]
57. Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women. Casson PR, Faquin LC, Stentz FB, Straughn AB, Andersen RN, Abraham GE, Buster JE. Fertil Steril; 1995 May 17; 63(5):1027-31. PubMed ID: 7720912 [Abstract] [Full Text] [Related]
58. Dehydroepiandrosterone for the treatment of systemic lupus erythematosus. van Vollenhoven RF. Expert Opin Pharmacother; 2002 Jan 17; 3(1):23-31. PubMed ID: 11772330 [Abstract] [Full Text] [Related]
59. Long-term administration of intravaginal dehydroepiandrosterone on regression of low-grade cervical dysplasia--a pilot study. Suh-Burgmann E, Sivret J, Duska LR, Del Carmen M, Seiden MV. Gynecol Obstet Invest; 2003 Jan 17; 55(1):25-31. PubMed ID: 12624548 [Abstract] [Full Text] [Related]